Patients with acute myeloid leukemia who have lower education levels and lower income are less likely to receive an ...
A Yale School of Medicine team has created lists of criteria to help clinicians determine when next-generation sequencing ...
(RTTNews) - Moleculin Biotech, Inc. (MBRX), Wednesday announced the preliminary activity of Annamycin in heavily pretreated, relapsed/refractory acute myeloid leukemia or AML patients who had ...
Carla Harris has been diagnosed with and beaten acute myeloid leukemia thanks to a bone marrow transplant from her sister, ...
AFM28, a bispecific, tetravalent innate cell engager (ICE®) targeting CD123 and CD16A, achieved a 40% composite complete remission rate (CRcR) at ...
The first comprehensive map of the dramatic changes that take place in the blood system over the course of the human lifetime could have implications for the treatment of acute myeloid leukemia and ...
The FDA has granted fast track designation to LBS-007 for the treatment of patients with acute myeloid leukemia.
Conventional parameters for risk stratification prognosis for patients with low-risk myelodysplastic neoplasms, especially ...
Curis, Inc. ("Curis") (NASDAQ: CRIS), a biotechnology company focused on the development of emavusertib (CA-4948), an orally ...
A phase 3 trial of uproleselan in relapsed/refractory acute myeloid leukemia failed to meet the primary overall survival end ...
Drummer Clayton "Goose" Holyoak had to leave the Better Lovers tour due to his daughter's leukemia diagnosis, for which there ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback